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Objective: Individuals meeting all criteria for anorexia nervosa (AN) except that
weight falls within or above the normal range despite significant weight loss are cate-
gorized as having atypical AN (AAN). Existing research has provided mixed evidence
concerning the diagnostic demarcation of AN and AAN. The aim of the present study
was to identify research priorities for furthering the understanding of AN and AAN
as diagnostic entities.
Method: Employing the Delphi methodology, experts in the field were invited to sug-
gest research questions that need to be explored in the demarcation of AN from
AAN. This yielded 24 research areas, that were presented in subsequent rounds
where panelists were asked to prioritize areas of primary interest.
Results: Fifty-three panelists completed all three Delphi rounds. Consensus was only
reached on three items considered to be of primary interest: medical, neurobiological,
and neurological factors; epidemiology and natural course; and treatment response in
AAN compared to AN. In contrast, questions of premorbid weight and determining
the need for and nature of a body mass index cutoff differentiating between AAN
and AN were seen as being of low priority.
Discussion: These findings reveal a relatively low degree of consensus on the demar-
cation of AN from AAN in the field of eating disorders. A reason could be that the
definition and use of the AAN category vary in research and clinical practice. In order
to achieve further diagnostic clarity, research on the demarcation of AAN and AN
should focus on the identified prioritized research areas.
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1 | BACKGROUND
In the fourth edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV), meeting all criteria for anorexia nervosa
(AN) except that weight falls within the normal range despite signifi-
cant weight loss was subsumed under the Eating Disorder Not Other-
wise Specified category (American Psychiatric Association, 1994).
With the introduction of the fifth edition of the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM-5) in 2013, this clinical
condition—i.e., AN symptomatology in the absence of underweight—
was named atypical anorexia nervosa (AAN) and recognized as one of
the examples within the Other Specified Feeding and Eating Disorders
category (American Psychiatric Association, 2013). Notably, in con-
trast to the previous edition, the DSM-5 criteria also explicitly specify
that the weight of an individual with AAN may be above the normal
range.
Clinicians and researchers have noted an anecdotal increase in
the number of patients presenting for treatment with a restricting-
type eating disorder who meet all diagnostic criteria for AN except
that their body mass index (BMI) is within the normal, overweight, or
obese weight ranges. In a study on adolescents admitted to hospital
because of a restrictive eating disorder, 8% fell in the AAN category in
2005 compared to 47% in 2009 (Whitelaw, Gilbertson, Lee, &
Sawyer, 2014). AN symptomatology in the absence of underweight
has increasingly been described as an overlooked concern, both in the
scientific literature (Neumark-Sztainer, 2015) and in popular media
(Dennett, 2019; Tait, 2015).
A retrospective cohort study of adolescent patients with a restric-
tive eating disorder presenting for intake evaluation showed that the
group of patients that fell in the overweight or obese weight range
before the onset of eating disorder symptoms (36.7% of the sample)
had a mean duration of illness of almost 20 months before intake
compared with just over 11 months for the group of patients with a
pre-onset weight within the normal range—i.e., detection of eating
pathology was substantially longer for those with BMIs in the over-
weight/obese range (Lebow, Sim, & Kransdorf, 2015). Similarly, a case
series described how two adolescent patients with severe restrictive
eating disorders and marked weight loss went largely unrecognized by
their primary care physicians, primarily because their BMIs were
within the obese range at the onset of illness (Sim, Lebow, &
Billings, 2013). There appears to be an obvious risk that weight loss in
an individual with overweight or obesity is seen by default as solely
positive against a backdrop of “the obesity epidemic” and the poten-
tial medical complications associated with obesity. Moreover, both
the affected individual as well as family members may be less inclined
to consult a physician when dramatic weight loss occurs in a context
of previous or concurrent overweight or obesity.
Within this context, several authors and individuals with lived
experience call for clinical recognition of individuals who experience
extreme weight loss, evidence of under- or malnutrition, and cognitive
and behavioral signs and symptoms of an eating disorder regardless of
weight (Forney, Brown, Holland-Carter, Kennedy, & Keel, 2017;
Neumark-Sztainer, 2015; Sawyer, Whitelaw, Le Grange, Yeo, &
Hughes, 2016; Sim et al., 2013; Whitelaw et al., 2014; Whitelaw, Lee,
Gilbertson, & Sawyer, 2018).
1.1 | How different are AN and AAN?
Some studies have pointed to overall similarities between AN and
AAN patients in terms of illness severity. A study on adolescents with
restrictive eating in a specialized eating disorders program found that
compared to patients with AN, the group of adolescents with AAN
were more often overweight or obese premorbidly and had lost more
weight over a longer period of time at presentation (Sawyer
et al., 2016). No group differences were observed between AN and
AAN patients in terms of resting pulse rate, frequency of bradycardia,
marked orthostatic changes, hypothermia, or need for hospital admis-
sion at presentation. Systolic blood pressure was higher and amenor-
rhea was less frequent in the AAN group. The AAN group reported
significantly more severe eating disorder symptoms on all subscales of
the Eating Disorders Examination Questionnaire (EDE-Q)—the
authors argue that this is an expected finding, given that a higher BMI
is generally associated with greater body image concerns. There were
no significant group differences regarding the occurrence of binge
eating, vomiting, laxative misuse, or compulsive exercise. Also, the
prevalence of psychiatric comorbidity, self-harm or suicidal ideation,
depressive symptomatology, obsessive–compulsive traits, or psycho-
tropic medication did not differ between the AN and AAN groups.
Another study by the same group of researchers investigated
medical complications such as bradycardia or hypophosphatemia in
adolescents with either AN or AAN hospitalized because of a restric-
tive eating disorder (Whitelaw et al., 2018). In sum, the authors con-
clude that total weight loss and recent weight loss were more
accurate predictors of somatic complications of restrictive eating than
the admission weight per se.
In contrast, in a recent study on bone health in men with AN,
AAN, and avoidant/restrictive food intake disorder (ARFID), the AN
group was at higher risk of lower bone mineral density and hip
strength than the other groups although bone mineral density was
also reduced in AAN and ARFID (Schorr et al., 2019). Here, the
authors conclude that from a bone health perspective, the absence of
a history of underweight may be relatively protective.
Small-scale studies of brain structure and function have pointed
to potential pathogenetic differences between AN and AAN. For
example, in contrast to AN, alterations in gray and white matter
microstructure do not appear to be common features of AAN; how-
ever, this may reflect less severe undernutrition in AAN (Olivo
et al., 2018; Olivo et al., 2019). Moreover, food-related neural
responses in AAN may differ from what is typically seen in AN (Olivo
et al., 2019).
The flexibility in defining significant weight loss in AAN inherent
to the DSM-5 criteria may be reasonable in clinical settings, but is dif-
ficult to operationalize in research. In a study of an adult nonclinical
cohort, three definitions of AAN with different levels of lifetime
weight loss (>5%, >10%, and >15%) were tested (Forney et al., 2017).
1730 STRAND ET AL.
Comparisons were also made with participants who had lost weight
but did not have cognitive eating disorder concerns (i.e., criteria B and
C of DSM-5 AN), as well as those with cognitive concerns but no
weight loss. A vast majority of participants categorized as AAN
reported previous weights in the overweight and obese ranges. At all
three definitions of significant weight loss, the AAN group displayed
elevated eating pathology and distress compared with healthy con-
trols. In comparison with other DSM-5 eating disorders, women in the
AAN group displayed somewhat less severe eating pathology and dis-
tress, whereas these levels were similar for men in the AAN and other
DSM-5 eating disorders groups. The AAN group was also clearly dis-
tinguishable from the groups with only weight loss or cognitive con-
cern regarding eating pathology and distress. It should be noted that
this sample was nonclinical and that lifetime weight loss was studied,
not recent weight loss. Moreover, a clinical observation is that the
impaired insight into the severity of their symptoms that characterize
some individuals with AN (Gorwood, Duriez, Lengvenyte, Guillaume, &
Criquillion, 2019; Konstantakopoulos, Tchanturia, Surguladze, &
David, 2011) could lead them to underreport on cognitive measures
of AN. Whether this also holds true for individuals in the AAN cate-
gory is uncertain.
Furthermore, diagnostic overlap between AAN and purging disor-
der has also been suggested. In the above study, 57% of participants
with purging disorder and 52% with bulimia nervosa also met AAN
criteria at the 5% weight loss definition (Forney et al., 2017).
Understanding the differences and similarities between AN and
AAN is important as clinicians caring for patients with AAN may have
to weigh several factors when developing a treatment plan. The
approach to renourishment may differ when weight gain is not a med-
ical necessity. Simply transferring recommended renourishment pro-
tocols for AN to individuals with AAN may not be the optimal
approach to achieve remission and health (Nagata, Garber, &
Buckelew, 2018). In a small treatment study of family-based treatment
(FBT) for families of adolescents with AAN, eating disorder cognitions
and behaviors improved but weight increased only slightly (Hughes,
Le Grange, Court, & Sawyer, 2017). The mean BMI was 21.0 kg/m2 at
baseline and 21.6 kg/m2 post-treatment. Remission rates were similar
or even superior to those reported in clinical trials of FBT for adoles-
cent AN; however, the authors note that assessing treatment success
in AAN is complex since the criterion of rapid weight restoration used
in evaluation of FBT in AN does not apply. It is possible that weight
restoration to premorbid levels in AAN could further improve remis-
sion rates, but the authors' experience is that healthcare providers,
patients, and families are reluctant to consider this option because of
the medical risks associated with overweight and obesity. Another
recent study on weight-gain trajectories in FBT for adolescents with
restricting eating disorders found that for AAN patients, the most
common trajectory was an initial shallow slope of weight gain with a
subsequent return to their pre-intervention BMI and an overall weight
maintenance at the 60th percentile throughout treatment (Lebow
et al., 2019).
Also of note is that in a large retrospective review of DSM-5 eat-
ing disorder diagnoses, 27.3% of patients with an AAN diagnosis had
a < 90% median BMI at intake and 13.7% of patients with an AN diag-
nosis had a ≥ 90% median BMI at intake (Forman et al., 2014). Clearly,
the AAN and AN diagnostic criteria are not uniformly applied in clini-
cal settings.
Importantly, AAN is defined differently in the tenth edition of the
International Statistical Classification of Diseases and Related Health
Problems (ICD-10) (World Health Organization, 2004) than in the
DSM-5, which affects the study populations in investigations of AAN
utilizing these diagnostic systems. Studies that define AAN according
to the ICD-10 criteria will thus include individuals with AN-type
restrictive eating without underweight, but also individuals without
amenorrhea (categorized as AN in the DSM-5) or those without mar-
ked fear of gaining weight (possibly categorized as ARFID in the
DSM-5; for an example, see Silén et al., 2015).
In sum, some studies indicate that AN and AAN are very similar in
terms of clinical characteristics, such as level of cognitive restraint or
medical consequences of the restrictive energy intake (Sawyer
et al., 2016; Whitelaw et al., 2018). Based on findings such as these,
some argue that the most important body weight measure in any restric-
tive eating disorder is the total amount of body weight that has been
lost, rather than the actual current body weight. Others, however, main-
tain that there are important differences between AN and AAN and that
patients do not benefit from these diagnoses being conceptualized as a
single clinical entity (Olivo, Zhukovsky, et al., 2019; Schorr et al., 2019).
Importantly, in some healthcare systems the current diagnostic division
affects insurance coverage and may result in reduced access to treat-
ment for patient groups relegated to the “atypical” sphere, underscoring
the need of examining the validity of this demarcation.
1.2 | Objective
The aim of the present study was to identify research priorities for
furthering the understanding of AN and AAN as diagnostic entities.
By employing the Delphi methodology (described in detail in the
Methods section), we surveyed which research questions that experts
within the field—researchers, clinicians, and patient advocates—think
need to be asked and answered in order to determine whether AN
and AAN are the same or different conditions. We expected that the
Delphi panel would generate a substantial number of potentially
important research questions regarding AAN and that there would be
a certain level of disagreement among the panel members regarding
which of these questions are most relevant and should be prioritized,
but also that they would be able to reach consensus (i.e., ≥85% agree-
ment as described below) on several of these issues.
2 | METHODS
2.1 | The Delphi method
The Delphi methodology was developed in the 1960s as a method for
analyzing and achieving consensus in questions concerning future
STRAND ET AL. 1731
needs and developments (Helmer-Hirschberg, 1967). Over the years,
the Delphi method has increasingly been used in medical research for
charting levels of consensus regarding clinical practice and research
priorities (Hasson, Keeney, & McKenna, 2000; Hsu & Sanford, 2007;
Keeney, Hasson, & McKenna, 2006; Powell, 2003; Sinha, Smyth, &
Williamson, 2011). In a Delphi study, a panel of experts is invited
(through mail or, more commonly, email or an online survey platform)
to answer one or more predefined questions at issue concerning topi-
cal developments in their field of expertise. Recurring themes within
their answers are then identified through qualitative content analysis
or similar approaches. In a second Delphi round, these synthesized
themes are fed back to the panel members, who are then asked to
answer whether they agree or disagree on a number of statements
derived from the panel's initial answers. This process yields quantita-
tive data on level of agreement within the group. These data are once
more fed back to the panel in a third Delphi round, whereby the
respondents are also informed about how the group as a whole has
answered on the various questions. Respondents are then asked to
revisit their position based on this information; if they maintain an
opinion that differs markedly from the rest of the panel, they are
asked to provide a rationale. Under certain circumstances, a fourth
Delphi round may be used in order to achieve a maximum level of
consensus, but previous experience shows that this is rarely
necessary.
The purpose of this procedure is to explore which questions the
panel members are able to reach consensus on (usually defined as at
least 85% agreement within the group). Of course, the final outcome
may also be a stabilized non-consensual, polarized distribution rather
than consensus for some (or all) items. The anonymity within the
panel makes it easier for those who hold an opinion that differs from
the rest of the group to be heard and to argue for their position. In
the field of eating disorders research, the Delphi methodology has
previously been employed in order to, for example, explore consensus
regarding recommendations on physical exercise for individuals with
eating disorders (Noetel, Dawson, Hay, & Touyz, 2017), dieticians'
opinions regarding nutritional recommendations (Mittnacht &
Bulik, 2015), or steps of care and staging of illness in AN (Buchman,
Attia, Dawson, & Steinglass, 2019; Steinglass, Glasofer, Dalack, &
Attia, 2020).
Existing guidelines for Delphi studies do not provide a definitive
recommended sample size (i.e., how many experts that should be
invited to participate in the Delphi expert panel). Based on the topic
in question and the scope of the research field, a Delphi panel may
include anywhere from a couple of experts to several hundred respon-
dents. A common approach is to invite between 40 and 80 experts,
with the aim of securing an expert panel of 20 to 40 persons after
dropout.
2.2 | Participants and procedures
In the present study, the Delphi methodology was employed with an
aim of three Delphi rounds in total. Panel members were invited
based on having displayed an established interest and expertise in AN,
AAN, and/or conceptual diagnostic questions, as demonstrated by
either:
1. current Fellow of the Academy for Eating Disorders (AED) status;
2. membership of the Eating Disorders Research Society (EDRS);
3. appointment as a Professor or Associate Professor in the field of
eating disorders;
4. spent 10 years or more working in the field;
5. published peer-reviewed journal article(s) and/or book(s) that are
focused on AN, AAN, and/or conceptual diagnostic questions;
6. awarded the AED Meehan/Hartley Leadership Award for Public
Service and/or Advocacy; or
7. participation as committee members in working groups for the
development of DSM-5 or ICD-11 diagnostic criteria.
The above criteria and key publications in the field were used to
develop a list of potential panelists, who were then invited by email
to participate in the Delphi survey. All panelists were anonymous to
each other. In the invitation email, the Delphi procedures were thor-
oughly explained; for example, the importance of committing to
responding to all three rounds was stressed, but it was also explicitly
stated that participation was fully voluntary and that the respon-
dents were free to opt out of further participation at any time during
the study.
In Delphi round 1, 127 invited panelists were sent a link to an
online questionnaire where they were asked to respond in free text to
the following question (after having been provided a description of
current AN and AAN diagnostic criteria): “In your opinion, which
research questions need to be asked and answered in order to deter-
mine whether AN and AAN are the same or different conditions?”
The answers from the 78 responding panelists (61% of those invited)
were processed by employing a qualitative content analysis approach
(Hsieh & Shannon, 2005), conducted in parallel by two of the authors
(AB and MS). The data were coded and labelled inductively according
to a bottom-up principle, and then re-coded in a top-down approach
to make sure that the coding scheme was accurate and reliable. The
overarching perspective in responses (as per instructions) was com-
parisons between AN and AAN. Responses were grouped into broad
themes and narrow categories which then became the basis for for-
mulating 24 items for Delphi round 2.
In Delphi round 2, the instruction text for the questionnaire was:
“In your opinion, which of the following research areas are the most
important and timely to focus on in order to determine whether AN
and AAN are the same or different conditions? Although many
research questions may be important, try to in some sense prioritize
the areas that you believe are of primary interest at this point.”
Respondents were then provided Likert scales ranging from 1 to 6
(i.e., from “Strongly disagree” to “Strongly agree”) for the 24 items
identified in round 1.
The round 2 questionnaire was completed by 62 respondents
(79% of round 1 respondents). In the subsequent round 3, the same
items were repeated again with the following instruction: “In this third
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and final round, we present you with the 24 items from round
2 together with the distribution of responses from all participants in
round 2. In this round, we ask you to revisit your answers using the
same scale.” 53 respondents (68% of round 1 respondents; 85% of
round 2 respondents) completed the round 3 questionnaire. For item
10, >85% consensus was already reached in round 2 and respondents
scoring outside the consensus range in round 3 were asked to com-
ment on their choice.
For the present study, consensus was defined as achieving ≥85%
of panelists choosing the rankings “Strongly agree” or “Agree”
(i.e., positive consensus) or “Strongly disagree” or “Disagree”
(i.e., negative consensus). Near consensus was declared when
between 75% and 85% of panelists showed either agreement or dis-
agreement, and no consensus was declared when less than 75% of
panelists showed either agreement or disagreement. No data were
excluded based on attrition; i.e., every contribution to every round
was included in the synthesis. However, the final consensus ratios
were calculated based on the answers from those panelists who actu-
ally completed the Delphi round 3.
Data collection was administered through the online survey plat-
form Confirmit, which is a standard web platform employed by
Karolinska Institutet. Study data were handled in accordance with
Swedish Data Security Regulations (GDPR) and the integrity and
safety policies at Karolinska Institutet. The study was approved by the
Swedish Ethical Review Authority (No. 2019–02518). The study pro-
tocol was preregistered at the Open Science Framework (https://osf.
io/efp63/). Two analyses were subsequently added to this protocol.
First, because of attrition between rounds, a sensitivity analysis was
performed whereby answers from round 2 were carried forward to an
artificial round 3 in which we simulated that the responses from round
TABLE 1 Proportion of respondents in Delphi round 3 who scored 1–2 and 5–6 respectively (where ≥85% in either is consensus by the a
priori criterion)
Item (”Research should focus on….”)
Round 3 (n = 53)
% ≤2 % ≥5 Median
…treatment response in AAN compared to AN 0.0 94.7 6
…medical, neurobiological, and neurological factors in AAN compared to AN 5.7 90.6 6
…the epidemiology and natural course of AAN compared to AN 3.8 86.8 5
…the degree of functional impairment in AAN compared to AN 5.7 83.0 6
…psychiatric comorbidity in AAN compared to AN 0.0 83.0 5
…cognitive and behavioral eating disorder psychopathology in AAN compared to AN 5.7 81.1 6
…psychological features and risk factors such as personality, compulsivity, emotion
regulation, impulsivity etc. in AAN compared to AN
5.7 81.1 5
…the longitudinal association between AAN and AN 5.7 77.4 5
…neurocognitive impairment in AAN compared to AN 1.9 77.4 5
…the metabolic factors in AAN compared to AN 3.8 71.7 6
…qualitative research into patient experiences of AAN 11.3 71.7 5
…proportion of weight loss in AAN compared to AN 7.5 69.8 5
…weight suppression in AAN compared to AN 13.2 67.9 5
…whether weight loss is best determined by the individual's own weight loss or in
comparison to population norms
7.5 67.9 5
…comparisons with other eating disorders (e.g., BN, EDNOS, BED) 3.8 66.0 5
…speed of weight loss in AAN compared to AN 5.7 66.0 5
…the genetic overlap between AAN and AN 11.3 64.2 5
…familial risk factors in AAN compared to AN 13.2 56.6 5
…whether there are subgroups of AAN corresponding to restrictive vs. binge/purge AN 24.5 54.7 5
…premorbid weight in AAN compared to AN 11.3 47.2 4
…the degree, nature, and consequences of weight stigma in AAN compared to AN 30.2 45.3 4
…the demographic, developmental, and sociocultural risk factors in AAN compared to AN 1.9 43.4 4
…determining the need for, and nature of, a BMI cutoff between AAN and AN 39.6 37.7 3
…what societal benefits or harms may result from determining if AAN is different from
AN, and who the stakeholders are (patients, advocacy, health care, research etc.)
5.7 30.2 4
Note: Items are ranked in order of positive responses. Also displaying median value. Items on which consensus and near consensus were reached are
marked in grey.
Abbreviations: AAN: atypical anorexia nervosa; AN: anorexia nervosa; BED: binge-eating disorder; BMI: body mass index; BN: bulimia nervosa; EDNOS:
eating disorder not otherwise specified.
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2 for the non-participants of round 3 remained unchanged. We also
investigated how using the median of the responses as cutoff value
would affect results.
3 | RESULTS
In Table 1, the 24 items are ranked in order of positive round
3 responses. The distributions of panelist responses are shown in
Figure 1. Examples of panelist comments that the items are based on
are provided in Table S1. Positive consensus (i.e., ≥85% of panelists
agree or strongly agree) was reached for three items: (a) medical, neu-
robiological, and neurological factors in AAN compared to AN; (b) the
epidemiology and natural course of AAN compared to AN; and
(c) treatment response in AAN compared to AN.
Near positive consensus (i.e., between 75% and 85% positive
agreement) was observed for six additional items: (a) the degree of
functional impairment in AAN compared to AN; (b) cognitive and
behavioral eating disorder psychopathology in AAN compared to AN;
(c) psychiatric comorbidity in AAN compared to AN; (d) psychological
features and risk factors such as personality, compulsivity, emotion
regulation, impulsivity etc. in AAN compared to AN; (e) the longitudi-
nal association between AAN and AN; and (f) neurocognitive impair-
ment in AAN compared to AN.
Negative consensus (i.e., ≥85% of the panelists disagree or
strongly disagree) or near negative consensus (i.e., between 75% and
85% disagree or strongly disagree) was not seen for any item. The five
items that were furthest from positive consensus—indicating that pan-
elists had low consensus (i.e., high variability of responses even in
round 3) in determining the differences between AAN and AN—
included: (a) demographic, developmental, and sociocultural risk fac-
tors in AAN compared to AN; (b) premorbid weight in AAN compared
to AN; (c) determining the need for, and nature of, a BMI cutoff
between AAN and AN; (d) the degree, nature, and consequences of
weight stigma in AAN compared to AN; and (e) what societal benefits
or harms may result from determining if AAN is different from AN,
and who the stakeholders are (patients, advocacy, health care,
research etc.). The item with the largest proportion of negative
responses, although still far from negative consensus (39.6%), con-
cerned determining the need for, and nature of, a BMI cutoff between
AAN and AN. As seen in Figure 1, the panelist responses tended to be
centered around the middle of the scale for some of these items,
whereas a more polarized distribution of responses was seen for
others—e.g., concerning weight stigma and BMI cutoff—where slight
peaks were seen at both ends of the scale.
Since consensus was reached on relatively few items, we also
explored the use of median = 6 (meaning that ≥50% of responses had
a maximum rating of strongly agree) as a cutoff value. This criterion
F IGURE 1 Distribution of panelist responses (n = 53) in Delphi round 3 (on a Likert scale of 1–6, where 1 is “Strongly disagree” and 6 is
“Strongly agree”). Solid vertical lines indicate levels of 85% agreement. Dotted vertical lines indicate levels of 75% agreement. Only when these
lines fall on responses 5 or 6 is positive consensus or near consensus achieved
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would have resulted in positive consensus for three additional items
(some of which already reached near consensus): (a) the degree of
functional impairment in AAN compared to AN; (b) cognitive and
behavioral eating disorder psychopathology in AAN compared to AN;
and (c) the metabolic factors in AAN compared to AN.
The sensitivity analysis performed to assess the impact of attri-
tion did not alter the pattern of the findings.
4 | DISCUSSION
Existing research has provided mixed evidence concerning the diag-
nostic demarcation of AN and AAN. The present study reveals that
there is indeed relatively little consensus on this topic in the field of
eating disorders research and advocacy. Out of 24 identified items of
interest, 53 Delphi panelists only reached consensus, defined as ≥85%
agreement, on three items that they considered to be of primary inter-
est for follow-up: medical, neurobiological, and neurological factors in
AAN compared to AN; the epidemiology and natural course of AAN
compared to AN; and treatment response in AAN compared to
AN. These items can be described as fairly traditional in the context of
medical diagnostics—they are, for example, all included in the
Feighner criteria for determining the validity of diagnoses (Feighner
et al., 1972)—and it is therefore not surprising that a high level of
agreement was seen.
Negative consensus, that is, ≥85% agreement about the relative
unimportance of particular items, was not found. However, on five
items, less than half of the panelists agreed or strongly agreed,
suggesting that these areas had low consensus in determining
whether they should be prioritized in determining the differences
between AAN and AN. Notably, these included the question of
premorbid weight in AAN compared to AN and determining the need
for and nature of a BMI cutoff differentiating between AAN and AN—
in fact, the latter was the item with the largest proportion of negative
responses (39.6%). This is a surprising finding given the central nature
of body weight in the demarcation of AN and AAN in DSM definitions
as well as in popular debate (Dennett, 2019; Tait, 2015). Likewise, nei-
ther positive nor near positive consensus was achieved for the items
concerning proportion and speed of weight loss in AAN compared to
AN or whether weight loss is best determined by the individual's own
weight loss or in comparison to population norms. Here, it should be
noted that the question posed to the Delphi panelists was not
whether they consider a certain item, such as body weight, as relevant
to the diagnosis of AN and/or AAN, but whether they think it would
be of primary interest to determine how the potential research prior-
ity impacts the demarcation of AN and AAN. Thus, the question of
body weight and a weight cutoff was not seen as very important in
elucidating the nature of AAN in relation to AN in the current study.
Moreover, neither positive nor near positive consensus was
achieved for the item concerning the degree, nature, and conse-
quences of weight stigma in AAN compared to AN—with 30.2% nega-
tive responses, this was the second most negatively rated item. This is
also somewhat surprising, given the emphasis on potential weight
stigma in popular media reporting as well as in academic papers focus-
ing on how clinicians' preconceptions may delay adequate assessment
and treatment for individuals with overweight (Lebow et al., 2015;
Sim et al., 2013). Likewise, the item concerning the demographic,
developmental, and sociocultural risk factors in AAN compared to AN
was also among the lowest ranking research priorities. Since the prob-
lem of weight stigma seems to be exacerbated by a low socioeco-
nomic status (Ciciurkaite & Perry, 2018), it is noteworthy that both
items relating to these issues received comparably low rankings.
In recent years, considerable advances have been made in the
field of the genetics of eating disorders in general (Breithaupt,
Hübel, & Bulik, 2018; Bulik, Kleiman, & Yilmaz, 2016) and AN in par-
ticular (Hübel et al., 2019; Watson et al., 2019). Even so, in the pre-
sent study, positive or near positive consensus was not achieved for
the item concerning a genetic overlap between AAN and AN, meaning
panelists did not emphasize degree of genetic similarity to be a high
priority in defining the boundaries between AN and AAN. Considering
that the item concerning the demographic, developmental, and socio-
cultural risk factors was also among the lowest ranking, research ques-
tions concerning the etiology of AAN and AN were clearly not
prioritized, although near consensus was achieved for the item con-
cerning the longitudinal association between AAN and AN.
The findings presented here should be considered in light of a
number of limitations. Even if a list of predefined eligibility criteria is
adhered to, a Delphi study inevitably involves a selective sample of
panelists, which may affect the outcome. Naturally, although the
rationale behind inviting panelists based on organizational fellowship,
professorial status etc. is to ensure scientific merit, this may also intro-
duce demographic and socioeconomic bias. Another potential limita-
tion is the attrition rate with 53 respondents (i.e., 42% of the
127 invited respondents and 68% of the 78 round 1 panelists)
remaining in the panel until round 3. Between rounds 2 and 3,
however, a good response rate was achieved with 85% of round
2 respondents completing round 3. Bearing in mind the general rec-
ommendation of securing an expert panel of at least 20 to 40 persons
after dropout, our study adhered to this guideline across all rounds. A
sensitivity analysis simulating an artificial round 3 with all round 2 par-
ticipants did not alter the results.
Furthermore, respondents were explicitly asked to prioritize the
areas that they consider to be of primary interest for research at this
point. Therefore, a lack of positive consensus regarding a certain item
does not readily implicate that it is unimportant, merely that it is not
seen as being of primary importance relative to the other suggested
items. Indeed, the overall lack of negative consensus means that there
were no research questions that were seen as unimportant. Moreover,
there are a number of hypothetical response biases inherent to Likert-
type survey research, such as order effects bias (i.e., the impact of the
order in which questions appear), end aversion (i.e., the tendency to
avoid end-of-scale answers; this would make consensus less likely), or
an opposite tendency for extreme end-of-scale answers (which would
inflate consensus).
Despite efforts to include respondents from eating disorder advo-
cacy organizations in the Delphi panel, only a small number (n < 5)
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identified themselves as primarily advocates. The majority of partici-
pating panelists were included based on their membership in profes-
sional organizations for researchers and clinicians in the field. It is
important to note that the lines between these categories are in no
way absolute. For example, many clinicians and researchers are
involved in advocacy work or have lived experience and many
patients and family members go on to receive clinical degrees and par-
ticipate in or conduct research. The question of the nature of AAN in
relation to AN has at times been seen as controversial (e.g., the chal-
lenges of individuals with AAN in receiving treatment viewed as sec-
ondary to weight stigma). Although a survey of research priorities may
appear as a benign effort in this regard, it is possible that the act of
participation in the study could be experienced as legitimizing a con-
tested mainstream biomedical view for some invited panelists. This is
a shortcoming of the study since achieving consensus in the field
would ideally also involve participation of non-researcher experts and
experts by lived experience. In a broader sense, it has been under-
scored that the polarization within the field is lamentable, “creating
tension that has important ramifications for the ways in which we
structure research, intervention, and treatment efforts” (Trainer,
Brewis, Hruschka, & Williams, 2015, p. 62) and ultimately hindering
progress towards a better understanding of all individuals with restric-
tive eating disorders. Increased collaboration between the eating dis-
order and obesity research fields could aid in exploring the
intersection between eating disorders and overweight/obesity
(Neumark-Sztainer, 2009).
5 | CONCLUSION
In sum, the findings from the present Delphi study reveal relatively lit-
tle consensus within the field of eating disorders research and advo-
cacy on the topic of which research questions need to be answered in
order to further elucidate the relationship between AAN and AN. Out
of a list of 24 research topics identified by the Delphi panel, consen-
sus (defined as ≥85% agreement) were reached on three items—medi-
cal, neurobiological, and neurological factors in AAN compared to AN;
the epidemiology and natural course of AAN compared to AN; and
treatment response in AAN compared to AN—which can be described
as fairly traditional in a context of medical diagnostics.
Naturally, prioritizing research in these high-consensus areas does
not imply that low-consensus areas, such as a weight cutoff, should
not be explored. For example, in the high-priority treatment response
area, studies could focus on non-weight-based outcomes while still
acknowledging that changes in body weight do represent a central
component of recovery in some eating disorders.
A reason behind the overall lack of consensus could be that the
definition and use of the AAN category vary in research and clinical
practice (Forman et al., 2014; Forney et al., 2017; Silén et al., 2015). It
has been noted that certain internal inconsistencies in the AAN and
AN diagnostic criteria in the DSM-5 exist (Birgegård, Groß, de Man
Lapidoth, & Norring, 2013), which may give rise to different
interpretations and misunderstandings. Therefore, a clearer diagnostic
operationalization of AAN may be needed. At this point, there appears
to be little consensual support for the concept of AAN being ade-
quately researched in order for it to be lifted out of the Other Speci-
fied Feeding and Eating Disorders category in the DSM-5 to become
a separate diagnosis in its own right. Based on the present study, in
order to achieve further diagnostic clarity, research on the demarca-
tion between AAN and AN should focus on medical and neurobiologi-
cal factors, on their respective epidemiological characteristics and
natural course, and on how treatment response differs in AAN com-
pared to AN.
ACKNOWLEDGEMENTS
Dr. Bulik acknowledges funding from the Swedish Research Council
(Vetenskapsrådet) grant no. 538-2013-8864 and National Institute of
Mental Health (R01MH120170 and R01MH119084).
CONFLICTS OF INTEREST
Dr. Bulik reports: Shire (grant recipient, Scientific Advisory Board
member); Idorsia (consultant); Pearson (author, royalty recipient).
DATA AVAILABILITY STATEMENT








American Psychiatric Association. (1994). DSM-IV: Diagnostic and Statisti-
cal Manual of Mental Illness (4th ed.). Washington, D.C: American Psy-
chiatry Publishing.
American Psychiatric Association. (2013). DSM-5: Diagnostic and Statistical
Manual of Mental Illness (5th ed.). Washington, DC: American Psychia-
try Publishing.
Birgegård, A., Groß, G., de Man Lapidoth, J., & Norring, C. (2013). DSM-5:
Problems and suggestions. Journal of Eating Disorders, 1(1), 8. https://
doi.org/10.1186/2050-2974-1-8
Breithaupt, L., Hübel, C., & Bulik, C. M. (2018). Updates on genome-wide
association findings in eating disorders and future application to preci-
sion medicine. Current Neuropharmacology, 16, 1102–1110. https://
doi.org/10.2174/1570159X16666180222163450
Buchman, S., Attia, E., Dawson, L., & Steinglass, J. E. (2019). Steps of care
for adolescents with anorexia nervosa—A Delphi study. International
Journal of Eating Disorders, 52(7), 777–785. https://doi.org/10.1002/
eat.23088
Bulik, C. M., Kleiman, S. C., & Yilmaz, Z. (2016). Genetic epidemiology of
eating disorders. Current Opinion in Psychiatry, 29(6), 383–388. https://
doi.org/10.1097/YCO.0000000000000275
Ciciurkaite, G., & Perry, B. L. (2018). Body weight, perceived weight stigma
and mental health among women at the intersection of race/ethnicity
and socioeconomic status: Insights from the modified labelling
approach. Sociology of Health & Illness, 40(1), 18–37. https://doi.org/
10.1111/1467-9566.12619
1736 STRAND ET AL.
Dennett, C. (2019, February 20). Anorexia knows no body type - and
thinking otherwise can be a barrier to treatment. Seattle Times.
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A. J., Winokur, G., &
Munoz, R. (1972). Diagnostic criteria for use in psychiatric research.
Archives of General Psychiatry, 26(1), 57–63. Retrieved from. https://
doi.org/10.1001/archpsyc.1972.01750190059011
Forman, S. F., McKenzie, N., Hehn, R., Monge, M. C., Kapphahn, C. J.,
Mammel, K. A., … Woods, E. R. (2014). Predictors of outcome at 1 year
in adolescents with DSM-5 restrictive eating disorders: Report of the
National Eating Disorders Quality Improvement Collaborative. Journal
of Adolescent Health, 55(6), 750–756. https://doi.org/10.1016/j.
jadohealth.2014.06.014
Forney, K. J., Brown, T. A., Holland-Carter, L. A., Kennedy, G. A., &
Keel, P. K. (2017). Defining “significant weight loss” in atypical
anorexia nervosa. International Journal of Eating Disorders, 50(8),
952–962. https://doi.org/10.1002/eat.22717
Gorwood, P., Duriez, P., Lengvenyte, A., Guillaume, S., & Criquillion, S.
(2019). Clinical insight in anorexia nervosa: Associated and predictive
factors. Psychiatry Research, 281, 112561. https://doi.org/10.1016/j.
psychres.2019.112561
Hasson, F., Keeney, S., & McKenna, H. (2000). Research guidelines for the
Delphi survey technique. Journal of Advanced Nursing, 32(4),
1008–1015. https://doi.org/10.1046/j.1365-2648.2000.t01-1-01567.x
Helmer-Hirschberg, O. (1967). Analysis of the Future: The Delphi Method.
https://www.rand.org/pubs/papers/P3558.html
Hsieh, H.-F., & Shannon, S. E. (2005). Three approaches to qualitative con-
tent analysis. Qualitative Health Research, 15(9), 1277–1288. https://
doi.org/10.1177/1049732305276687
Hsu, C.-C., & Sanford, B. A. (2007). The Delphi technique: Making sense of
consensus. Practical Assessment, Research & Evaluation, 12(10), 1–8.
Hübel, C., Gaspar, H. A., Coleman, J. R. I., Finucane, H., Purves, K. L.,
Hanscombe, K. B., … Breen, G. (2019). Genomics of body fat percent-
age may contribute to sex bias in anorexia nervosa. American Journal
of Medical Genetics Part B: Neuropsychiatric Genetics, 180(6), 428–438.
https://doi.org/10.1002/ajmg.b.32709
Hughes, E. K., Le Grange, D., Court, A., & Sawyer, S. M. (2017). A case
series of family-based treatment for adolescents with atypical anorexia
nervosa. International Journal of Eating Disorders, 50(4), 424–432.
https://doi.org/10.1002/eat.22662
Keeney, S., Hasson, F., & McKenna, H. (2006). Consulting the oracle: Ten
lessons from using the Delphi technique in nursing research. Journal of
Advanced Nursing, 53(2), 205–212. https://doi.org/10.1111/j.1365-
2648.2006.03716.x
Konstantakopoulos, G., Tchanturia, K., Surguladze, S. A., & David, A. S.
(2011). Insight in eating disorders: Clinical and cognitive correlates.
Psychological Medicine, 41(9), 1951–1961. https://doi.org/10.1017/
S0033291710002539
Lebow, J., Sim, L. A., & Kransdorf, L. N. (2015). Prevalence of a history of
overweight and obesity in adolescents with restrictive eating disor-
ders. Journal of Adolescent Health, 56(1), 19–24. https://doi.org/10.
1016/j.jadohealth.2014.06.005
Lebow, J., Sim, L., Crosby, R. D., Goldschmidt, A. B., Le Grange, D., &
Accurso, E. C. (2019). Weight gain trajectories during outpatient
family-based treatment for adolescents with anorexia nervosa. Interna-
tional Journal of Eating Disorders, 52(1), 88–94. https://doi.org/10.
1002/eat.23000
Mittnacht, A. M., & Bulik, C. M. (2015). Best nutrition counseling practices
for the treatment of anorexia nervosa: A Delphi study. International
Journal of Eating Disorders, 48(1), 111–122. https://doi.org/10.1002/
eat.22319
Nagata, J. M., Garber, A. K., & Buckelew, S. M. (2018). Weight restoration in
atypical anorexia nervosa: A clinical conundrum. International Journal of
Eating Disorders, 51(11), 1290–1293. https://doi.org/10.1002/eat.22953
Neumark-Sztainer, D. (2009). The interface between the eating disorders
and obesity fields: Moving toward a model of shared knowledge and
collaboration. Eating and Weight Disorders, 14(1), 51–58. https://doi.
org/10.1007/BF03327795
Neumark-Sztainer, D. (2015). Higher weight status and restrictive
eating disorders: An overlooked concern. Journal of Adolescent Health,
56(1), 1–2. https://doi.org/10.1016/j.jadohealth.2014.10.261
Noetel, M., Dawson, L., Hay, P., & Touyz, S. (2017). The assessment and
treatment of unhealthy exercise in adolescents with anorexia nervosa:
A Delphi study to synthesize clinical knowledge. International Journal
of Eating Disorders, 50(4), 378–388. https://doi.org/10.1002/eat.
22657
Olivo, G., Solstrand Dahlberg, L., Wiemerslage, L., Swenne, I.,
Zhukovsky, C., Salonen-Ros, H., … Schiöth, H. B. (2018). Atypical
anorexia nervosa is not related to brain structural changes in newly
diagnosed adolescent patients. International Journal of Eating Disorders,
51(1), 39–45. https://doi.org/10.1002/eat.22805
Olivo, G., Swenne, I., Zhukovsky, C., Tuunainen, A.-K., Saaid, A., Salonen-
Ros, H., … Schiöth, H. B. (2019). Preserved white matter microstructure
in adolescent patients with atypical anorexia nervosa. International Jour-
nal of Eating Disorders, 52(2), 166–174. https://doi.org/10.1002/eat.
23012
Olivo, G., Zhukovsky, C., Salonen-Ros, H., Larsson, E.-M., Brooks, S., &
Schiöth, H. B. (2019). Functional connectivity underlying hedonic
response to food in female adolescents with atypical AN: The role of
somatosensory and salience networks. Translational Psychiatry, 9(1),
276. https://doi.org/10.1038/s41398-019-0617-0
Powell, C. (2003). The Delphi technique: Myths and realities. Journal of
Advanced Nursing, 41(4), 376–382. https://doi.org/10.1046/j.1365-
2648.2003.02537.x
Sawyer, S. M., Whitelaw, M., Le Grange, D., Yeo, M., & Hughes, E. K.
(2016). Physical and psychological morbidity in adolescents with atypi-
cal anorexia nervosa. Pediatrics, 137(4), e20154080. https://doi.org/
10.1542/peds.2015-4080
Schorr, M., Drabkin, A., Rothman, M. S., Meenaghan, E., Lashen, G. T.,
Mascolo, M., … Miller, K. K. (2019). Bone mineral density
and estimated hip strength in men with anorexia nervosa,
atypical anorexia nervosa and avoidant/restrictive food intake disor-
der. Clinical Endocrinology, 90(6), 789–797. https://doi.org/10.1111/
cen.13960
Silén, Y., Raevuori, A., Jüriloo, E., Tainio, V.-M., Marttunen, M., & Keski-
Rahkonen, A. (2015). Typical versus atypical anorexia nervosa among
adolescents: Clinical characteristics and implications for ICD-11.
European Eating Disorders Review, 23(5), 345–351. https://doi.org/10.
1002/erv.2370
Sim, L. A., Lebow, J., & Billings, M. (2013). Eating disorders in adolescents
with a history of obesity. Pediatrics, 132(4), e1026–e1030. https://doi.
org/10.1542/peds.2012-3940
Sinha, I. P., Smyth, R. L., & Williamson, P. R. (2011). Using the Delphi tech-
nique to determine which outcomes to measure in clinical trials: Rec-
ommendations for the future based on a systematic review of existing
studies. PLoS Medicine, 8(1), 1–5. https://doi.org/10.1371/journal.
pmed.1000393
Steinglass, J. E., Glasofer, D. R., Dalack, M., & Attia, E. (2020). Between
wellness, relapse, and remission: Stages of illness in anorexia nervosa.
International Journal of Eating Disorders, 53, 1088–1096. https://doi.
org/10.1002/eat.23237
Tait, A. (2015). When you're both overweight and anorexic. Retrieved
March 1, 2019, from Broadly website: https://broadly.vice.com/en_
us/article/gvz7m7/when-youre-both-overweight-and-anorexic
Trainer, S., Brewis, A., Hruschka, D., & Williams, D. (2015). Translating
obesity: Navigating the front lines of the “war on fat.”. American Jour-
nal of Human Biology, 27(1), 61–68. https://doi.org/10.1002/ajhb.
22623
Watson, H. J., Yilmaz, Z., Thornton, L. M., Hübel, C., Coleman, J. R. I.,
Gaspar, H. A., … Consortium, E. D. W. G. of the P. G. (2019). Genome-
wide association study identifies eight risk loci and implicates
STRAND ET AL. 1737
metabo-psychiatric origins for anorexia nervosa. Nature Genetics,
51(8), 1207–1214. https://doi.org/10.1038/s41588-019-0439-2
Whitelaw, M., Gilbertson, H., Lee, K. J., & Sawyer, S. M. (2014). Restrictive
eating disorders among adolescent inpatients. Pediatrics, 134(3),
e758–e764. https://doi.org/10.1542/peds.2014-0070
Whitelaw, M., Lee, K. J., Gilbertson, H., & Sawyer, S. M. (2018). Predictors
of complications in anorexia nervosa and atypical anorexia nervosa:
Degree of underweight or extent and recency of weight loss? Journal
of Adolescent Health, 63(6), 717–723. https://doi.org/10.1016/j.
jadohealth.2018.08.019
World Health Organization. (2004). ICD-10: International statistical classifi-
cation of diseases and related health problems, 10th revision (2nd ed.).
Geneva, Switzerland: World Health Organization.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Strand M, Zvrskovec J, Hübel C,
Peat CM, Bulik CM, Birgegård A. Identifying research priorities
for the study of atypical anorexia nervosa: A Delphi study. Int
J Eat Disord. 2020;53:1729–1738. https://doi.org/10.1002/
eat.23358
1738 STRAND ET AL.
